Valuation : Rapid Micro Biosystems, Inc.

Market Cap 78.75M 67.8M 63.67M 58.12M 109M 7.49B 110M 754M 294M 3.8B 296M 289M 12.58B P/E 2026 *
-1.68x
P/E 2027 * -2.16x
Enterprise Value 78.75M 67.8M 63.67M 58.12M 109M 7.49B 110M 754M 294M 3.8B 296M 289M 12.58B EV / Sales 2026 *
2x
EV / Sales 2027 * 1.69x
Free-Float
81.07%
Yield 2026 *
-
Yield 2027 * -
1 day-3.18%
1 week-9.94%
Current month-29.81%
1 month-29.81%
3 months-24.11%
6 months-64.74%
Current year-48.45%
1 week 1.48
Extreme 1.48
1.72
1 month 1.48
Extreme 1.48
2.2
Current year 1.48
Extreme 1.48
4.94
1 year 1.48
Extreme 1.48
4.94
3 years 0.58
Extreme 0.58
4.94
5 years 0.58
Extreme 0.58
22.71
10 years 0.58
Extreme 0.58
27.04
Manager TitleAgeSince
Chief Executive Officer 57 2014-09-30
Director of Finance/CFO 56 2018-09-30
Chief Tech/Sci/R&D Officer - 2025-04-30
Director TitleAgeSince
Director/Board Member 56 2018-09-30
Director/Board Member 57 2014-09-30
Director/Board Member 77 2016-03-14
Date Insider Type Main position Quantity % Market Cap. Importance
7/24/26 Exercice

Director

7,016 0.0155%
7/22/26 Exercice

Chief Executive Officer

2,804 0.0062%
5/29/26 Free

Director

38,361 0.0921%
Change 5-day change 1-year change 3-year change Capi.($)
-2.87%-9.94%-36.92%+54.92% 78.75M
-1.17%-2.25%+26.06%+10.32% 230B
-0.75%-0.47%+5.06%-19.21% 152B
+0.31%+0.03%-20.34%+19.51% 132B
+2.58%-1.70%-54.83%-10.69% 67.88B
+0.92%+0.67%+11.42%+19.14% 52B
-0.99%-3.12%-17.97%-15.39% 51.05B
-0.80%-0.54%+21.88%+26.05% 43.38B
-0.70%+0.29%+38.94%+46.70% 40.74B
+0.25%+3.58%-11.15%+50.87% 34.67B
Average -0.34%-1.73%-3.78%+18.22% 80.34B
Weighted average by Cap. -0.27%-1.46%+2.72%+7.85%

Financials

2026 *2027 *
Net sales 39.32M 33.86M 31.79M 29.02M 54.52M 3.74B 54.91M 377M 147M 1.9B 148M 144M 6.28B 46.5M 40.04M 37.59M 34.32M 64.47M 4.42B 64.93M 445M 173M 2.24B 175M 171M 7.43B
Net income -44.53M -38.34M -36M -32.86M -61.74M -4.24B -62.18M -427M -166M -2.15B -167M -164M -7.11B -35.83M -30.85M -28.97M -26.44M -49.68M -3.41B -50.03M -343M -134M -1.73B -135M -132M -5.72B
Net Debt - -
Logo Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Employees
171
Date Price Change Volume
26-08-31 US$1.495 -4.78% 95,569
26-08-28 US$1.570 -2.48% 70,016
26-08-27 US$1.610 -3.59% 134,503
26-08-26 US$1.670 +0.60% 91,085
26-08-25 US$1.660 0.00% 186,642
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.570USD
Average target price
6.667USD
Spread / Average Target
+324.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RPID Stock